TrialAntimicrobial agents and chemotherapy2004

Phase 2, randomized, dose-ranging study evaluating the safety and efficacy of anidulafungin in invasive candidiasis and candidemia.

David S Krause et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.